tiprankstipranks
Trending News
More News >
TME Pharma N.V. (FR:ALTME)
:ALTME
France Market

TME Pharma N.V. (ALTME) Income Statement

Compare
3 Followers

TME Pharma N.V. Income Statement

Last quarter (Q2 2024), TME Pharma N.V.'s total revenue was €0.00, a decrease of ― from the same quarter last year. In Q2, TME Pharma N.V.'s net income was €-3.25M. See TME Pharma N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 17.00K€ 0.00€ 33.00€ 35.00€ 154.00
Gross Profit
€ -127.00K€ -92.00K€ -65.97K€ -62.97K€ -1.03M
Operating Expenses
€ 5.50M€ 12.00M€ 13.45M€ 5.75M€ 2.92M
Depreciation and Amortization
€ 144.00K€ 92.00K€ 66.00K€ 63.00K€ 47.00K
EBITDA
€ -5.07M€ -11.63M€ -12.88M€ -5.29M€ -810.00K
Operating Income
€ -5.62M€ -12.03M€ -13.27M€ -5.77M€ -3.95M
Other Income/Expenses
€ -1.11M€ -3.10M€ -1.19M€ -4.64M€ 3.09M
Pretax Income
€ -6.73M€ -15.13M€ -14.45M€ -10.41M€ -860.00K
Net Income
€ -6.74M€ -15.13M€ -14.45M€ -10.40M€ -861.00K
Per Share Metrics
Basic EPS
€ -1.34€ -11.66€ -19.85€ -29.15€ -6.99
Diluted EPS
€ -1.34€ -11.66€ -19.85€ -29.15€ -6.99
Weighted Average Shares Outstanding
5.02M 1.30M 727.94K 356.98K 123.10K
Weighted Average Shares Outstanding (Diluted)
5.02M 1.30M 727.94K 356.98K 123.10K
Currency in EUR

TME Pharma N.V. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis